Summary A prognostic index, previously derived in a group of 387 patients with primary breast cancer, has been recalculated for the same patients with over 5 years further follow-up and shown to be unchanged. The prognostic index has also been applied prospectively to a further group of 320 patients and shown to be similarly effective in identifying patients with either a very good or a very poor prognosis. It has been verified that the index applies to patients with primary breast cancer. Patients have now been divided into 5 prognostic groups, predicting 11% of patients with an almost normal survival and a further 10% with a very poor prognosis. The index is used to stratify patients to study the effects of treatment regimes within groups of similar patients.
It would be of considerable value in the management of breast cancer patients to be able to predict more accurately the clinical course of the disease at the time of initial treatment. In studies of breast cancer many factors may appear to indicate prognosis if studied in isolation or in small groups. To obtain a true indication of the prognostic importance of these factors it is necessary to employ a form of multivariate analysis such as that described by Cox (1972) which can make use of all the data from a group of patients having a wide range of survival times.
The method was applied to the Nottingham/Tenovus Breast Cancer Study by Haybittle et al. (1982) . Initially nine factors were recorded for each patient, but the results of the Cox analysis performed retrospectively showed only three factors to be significant indicators of prognosis, namely tumour grade, lymph node stage and tumour size. A further two factors, menopausal status and oestrogen receptor content, were approaching significance. A prognostic index was derived using only the three significant prognostic factors: I= 0.2 x size + stage + grade.
where size is in cm, stages A, B and C (see below) are coded 1-3 and grade is also coded 1-3.
The index was computed for each patient, who was then assigned to one of three prognostic groups: Good (1<3.4), Moderate (3.4 <I< 5.4) and Poor (1> 5.4) .
Lifetable analysis of the patients in the Good prognostic group showed a survival of 88% at 5 years against 21 % in the Poor prognostic group. Since the method of obtaining the index relied on the best fit to retrospective data it is essential to perfect the index prospectively. This paper applies the prognostic index prospectively to a second group of patients with primary breast cancer who have presented since since our first report.
The power of the prognostic factors might alter with time, e.g., factors predicting survival at 10 years might be different from those predicting 5 year survival. The analysis has been re-applied to the original group of patients, now with longer follow-up.
Patients and methods
The patients in the two groups were treated under the care of a single surgeon (RWB) 
Method of lanallsis
The relative importance of the prognostic factors was derived using the multiple regression technique described by Cox (1972) , which derives coefficients (B values) showing how each factor contributes to the hazard and their significance (Z values) . If Z> 1.96, B is significantly different from zero at the 5% level in a two-tailed test. Survival curves have been calculated using the life-table method with time divided into six-monthly intervals, and differences have been tested for significance using the test described by Mantel (1966) .
The prognostic factors selected for investigation were those with a Z value of > 1.5 in the original Cox analysis, namely menopausal status (a pre-menopausal woman being either still menstruating or having a plasma sample containing <50 IU1-l FSH), tumour size measured in the fresh mastectomy specimen, lymph node involvement judged by histological examination of node sample by triple node biopsy technique described elsewhere (Blamey et al., 1980) , tumour grade and oestrogen-receptor (ER) content of the primary (Haybittle et al., 1982) .
Lymph node involvement was classified as:
Stage A: Tumour absent from all three nodes sampled. , under the direction of one pathologist (CWE), and ER content was assayed at the Tenovus Institute, Cardiff, by the dextran coated charcoal method (Maynard & Griffiths, 1979 Haybittle et al. (1982) selected two groups which have either a very good prognosis (I<3.4) or a very poor prognosis (I>5.4), with about 22% of patients in each of these two groups (Table II) . Lifetable survival curves for each of the three prognostic groups were also calculated for the prospective group of patients and compared with those of the original group (Figure 1 ). There is a close similarity of the curves for each prognostic group with no significant difference between the survival curves in any prognostic group. There is a significantly higher proportion of patients in the Good prognostic group (33%) than for the original study group (Table II) . The distribution of prognostic factors in the original and prospective groups has been compared (Table III) . There is no significant difference in the distribution of lymph node stage or tumour grade but a significant change in the distribution of tumour size, with a very much higher proportion of small tumours in the prospective group. The distribution of prognostic index values for the combined study and prospective groups is shown in Figure 2 and indicates that index values lie almost entirely between the integer values. The survival curves obtained by using the integer values to separate the new prognostic groups are shown in Figure 3 , demonstrating a ranking order of survival according to the prognostic index value.
Discussion
The coefficients found by Cox analysis are such that they obtain the best discrimination for the particular set of data from which they were derived. Time (years) Figure 3 Survival curves for patients from both original and prospective groups (n = 707) according to integer value of prognostic index. therapies,. both in terms of locoregional disease control (Williams et al., 1985) and possibly survival.
Those patients with intermediate prognostic index values can now be clearly separated into 3 groups, which should result in better stratification of patients according to potential survival than was possible by use of the Good, Moderate and Poor groups defined previously. The annual percentage mortality rates for groups 3, 4, 5, 6 and 7 are 1.5, 3.5, 6. 20 and 32 respectively.
The Nottingham prognostic index, therefore, allows us to accurately predict survival patterns in groups of patients treated by simple mastectomy. This has enabled us to compare the outcome of newer treatment modalities, such as subcutaneous mastectomy with simple mastectomy, after stratification of patients into prognostic groups (Hinton et al., 1984) . Stratification using this index has allowed us to offer patients a choice of initial surgery, while still being able to accurately compare recurrence and survival data for patients choosing breast conservation with those choosing simple mastectomy.
We are currently examining other factors which may be of independent prognostic significance in order to more accurately predict the survival patterns of individuals within these defined groups.
